Fexofenadine HCl and Pseudoephedrine HCI
NDC 30142-447, Fexofenadine HCl and Pseudoephedrine HCI, tablet, extended release, from The Kroger Co..
- Product NDC
- 30142-447
- Status
- Listed
- Labeler
- The Kroger Co.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA076667
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/30142-447 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEXOFENADINE HYDROCHLORIDE60 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 30142-447-14 | 30142044714 | 4 BLISTER PACK in 1 CARTON (30142-447-14) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 30142-447 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/30142-447 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 30142-447. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.